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INTRODUCTION
Thyroid carcinoma is the fifth leading cancer worldwide, and its 
incidence is increasing,1 and 95% of these cancers are follicular 
cell origin-papillary (PTC), follicular (FTC), or anaplastic thy-
roid cancers (ATC).2 In spite of the optimistic survival rates for 
PTC and FTC, a subset of this population demonstrates resis-
tance to therapy, including radioiodine, and a propensity for 
more aggressive tumors with higher rates of extracapsular 
spread to the strap muscle and recurrent laryngeal nerve, tra-
cheal invasion, and metastasis to lymph nodes, as well as recur-
rence or distant metastasis.3,4 In particular, FTC is more likely to 
produce distant metastases, leading to a poorer prognosis for 
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FTC patients compared with PTC patients.1 Thus, it is necessary 
to identify the underlying mechanisms leading to increased ag-
gressiveness of FTC and develop novel methods to prevent the 
aggressive features of invasion and metastasis in FTC.
Cancer invasion to surrounding tissues or metastasis to other 
organs requires multi-phase processes, including epithelial-to-
mesenchymal transition (EMT),5 and it is the principal cause of 
mortality in patients with malignancies.6 Although EMT is a vi-
tal process for morphogenesis during embryonic development, 
it has been implicated in the invasiveness of malignancies.7 
During EMT, epithelial cells dedifferentiate, lose cell polarity 
and epithelial surface markers, express mesenchymal markers, 
display phenotypic alterations, and subsequently migrate and 
invade.8 The molecular hallmarks for EMT are the downregula-
tion of epithelial cell adhesion molecules, such as E-cadherin, 
and the upregulation of mesenchymal components, such as vi-
mentin and N-cadherin.9
Accumulating evidence has demonstrated hypoxia to be an 
important trigger of tumor cell invasion or metastases via hy-
poxic activation cascades, including hypoxia-inducible factor 
(HIF)-1.10 This molecule consists of an oxygen-sensitive alpha 
subunit (HIF-1α) and a constitutively expressed beta subunit 
(HIF-1β). HIF-1 activates many downstream signals involved in 
angiogenesis (VEGF),11 anaerobic metabolism (GLUT-1),12 con-
trol of intracellular pH (CA-9),13 DNA damage responses,14 and 
proliferation (p21 and p27),15 which are essential to cancer cell 
adaption, survival, and progression to overcome the stressful 
conditions of hypoxia.16,17 Hypoxia and HIF-1α are associated 
with tumor aggressiveness and poor prognosis in many differ-
ent types of cancers, including uterine, prostate, stomach, pan-
creas, breast, non-small cell lung, and nasopharyngeal can-
cers.18-20 Moreover, the potential clinical importance of HIF-1α 
as a novel therapeutic target in thyroid cancer was most recent-
ly suggested by various studies demonstrating its pathophysio-
logical role in thyroid cancer progression, aggressiveness, and 
metastasis.16,21 However, the underlying molecular mechanism 
of increased aggressiveness and the poor prognosis of thyroid 
cancers with HIF-1α overexpression are not fully understood.
The purpose of this study was to identify HIF-1α expression 
triggered by hypoxia and to explore whether HIF-1α activation 
is important for inducing the EMT phenotype associated with 
tumor migration and invasion. To the best of our knowledge, 
this is the first study evaluating the relationship between HIF-
1α and EMT in thyroid cancer.
MATERIALS AND METHODS
Cell lines and reagents 
Human follicular (FTC133 and ML1) and papillary (TPC1 and 
BCPAP) thyroid cancer cells were purchased from the Ameri-
can Type Culture Collection (Manassas, VA, USA), and human 
anaplastic thyroid cancer cells (FRO and 8505C) were kindly 
provided by Dr. Kim (Ajou University, Suwon, Korea). The 
FTC133, ML1, and TPC1 cell lines were maintained in high-glu-
cose Dulbecco’s modified Eagle’s medium (PAA, Pasching, Aus-
tria), while BCPAP, FRO, and 8505C cell lines were cultured in 
RPMI (Lonza, Wakersville, MD, USA) supplemented with 10% 
fetal bovine serum and penicillin-streptomycin at 100 U/mL 
(GIBCO, Carlsbad, CA, USA). The cells were cultured at 37°C 
with 5% CO2 under humidified conditions.
 
Exposure to hypoxia
To induce hypoxia, cells were placed in a sealed hypoxic incu-
bator (Thermo Fisher Scientific, Rochester, NY, USA) and con-
tinuously gassed with a manufactured mixture of 1% O2 with 5% 
CO2:N2 balance (37°C) for the indicated times. Control cells 
were incubated under normoxic conditions (21% O2, 5% CO2, 
37°C) for equivalent periods.
Western blot analysis 
Cells were lysed on ice in lysis buffer [10 mM Tris-HCl (pH 7.4), 
100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM NaF, 20 mM 
Na4P2O7, 2 mM Na3VO4, 1% Triton X-100, 10% glycerol, 0.1% 
SDS, 0.5% deoxycholate] (Invitrogen, Camarillo, CA, USA) sup-
plemented with 1 mM phenylmethylsulfonyl fluoride and pro-
tease inhibitor cocktail (Sigma, St. Louis, MO, USA). Whole cell 
extracts (20 μg/lane) were electrophoresed using 10% SDS-
polyacrylamide gels and electrotransferred to polyvinylidene 
fluoride membranes (Millipore, Schwalbach, Germany) as de-
scribed previously.3 The following antibodies were used for 
Western blotting: anti-HIF-1α (1:1000), -E-cadherin (1:500), -N-
cadherin (1:500), -vimentin (1:1000), -Twist (1:1000), -Slug 
(1:1000), and GAPDH (1:1000). All antibodies were purchased 
from Cell Signaling Technology, Inc. (Danvers, MA, USA).
Quantitative real-time PCR
Total RNA from cultured cells was extracted using TRIzol (Invit-
rogen, Burlington, ON, Canada) according to the manufactur-
er’s instructions. Complementary DNA was prepared using 
random primers and MuLv reverse transcriptase (Roche, Basle, 
Switzerland) according to the manufacturer’s instructions. Re-
al-time PCR reactions were performed in triplicate using a 1:10 
dilution of cDNA and the KAPA SYBR Fast ABI Prism 2X qPCR 
Master Mix on an ABI 7300 Real-Time PCR machine (Applied 
Biosystems, MA, USA). Data were collected and analyzed using 
the 7300 Real-Time PCR software. The relative quantification of 
the expressed genes was carried out using the comparative 
quantification method. All mRNA quantification data were 
normalized to GAPDH. The following primers were used: HIF-
1α: forward 5’-CTC AAA GTC GGA CAG CCT CA-3’, reverse 5’-
CCC TGC AGT AGG TTT CTG CT-3’; E-cadherin: forward 5’-
TGC CCA GAA AAT GAA AAA GG-3’, reverse 5’-GTG TAT GTG 
GCA ATG CGT TC-3’; vimentin: forward 5’-GAG AAC TTT GCC 
GTT GAA GC-3’, reverse 5’-GCT TCC TGT AGG TGG CAA TC-
3’; Twist: forward 5’-GGC GCT TTC TTT TTG GAC CT-3’, re-
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verse 5’-AGG AGA GAG CAG GAG GAC GG-3’.
Immunocytochemistry
Cells were cultured on microscope coverslips under hypoxic or 
normoxic conditions. After 16 h, slides were washed with phos-
phate-buffered saline (PBS), fixed for 20 min in 4% formalde-
hyde, and re-hydrated in PBS. After blocking for 45 min in 5% 
bovine serum albumin in PBS, the slides were incubated over-
night at 4°C with polyclonal rabbit anti-HIF-1α, -E-cadherin, 
and -vimentin antibodies (1:100; Cell Signaling Technology), 
washed with PBS, and incubated for 45 min with Alexa 488-la-
beled goat anti-rabbit antibodies or Alexa 568-labeled donkey 
anti-mouse antibodies (1:250; Molecular Probes, Inc., Eugene, 
OR, USA). The slides were washed with PBS and mounted us-
ing Duolink mounting medium with DAPI (Olink Bioscience, 
Sweden) and then analyzed using a LSM700 confocal micro-
scope (Carl Zeiss Vision, Germany).
Wound healing assay
To investigate cell migration, cells were plated in 6-well culture 
plates at a density of 1×105/well and grown to a subconfluent 
cell layer. When cells reached 90% confluence, a scratch was 
created in the cell monolayer using a sterile plastic pipette tip, 
and cells were washed twice with serum-free medium to re-
move cell debris. Mitomycin C (1 μg/mL) was applied to cells to 
block the cell proliferation effect. After 16–24 h of incubation, 
migrated cells in the wounded area were visualized and photo-
graphed under an inverted microscope.
Invasion (transwell) assay
Cell invasion under normoxic or hypoxic conditions was evaluat-
ed in Transwell chambers (24-well; Costar, Cambridge, MA, USA) 
as described previously.22 Initially, fibronectin (2 μg/filter) was dis-
solved in 100 μL of minimal essential medium and poured into the 
upper section of the polyethylene filter (pore size, 8 μm). The wells 
were coated overnight in a laminar flow hood, after which 5×105 
cells (in 100 μL growth medium) were added to the top of the filter 
in the upper well. The chamber was incubated for 12 h under nor-
moxic or hypoxic conditions with 5% CO2 at 37°C. Non-migrant 
cells located in the upper section of the filter were removed using a 
cotton swab. Finally, attached cells in the lower section were 
stained with crystal violet and counted using a light microscope.
HIF-1α transfection
HIF-1α overexpression was achieved by transfection with pcD-
NA3 HIF-1α-HA (Addgene, Cambridge, MA, USA) using Fugene® 
HD Transfection (Promega, Madison, WI, USA) according to the 
manufacturer’s recommended protocol. After transient trans-
fection for 24 h, cells were cultured for 4 weeks. HIF-1α positive 
cell clones were selected and expanded.
Silencing of HIF-1α (RNA interference)
Lentivirus-mediated short hairpin RNA (shRNA) silencing of 
HIF-1α: Stable FTC133 cells were generated by polybrene (Santa 
Cruz Biotechnology, Inc., CA, USA) transduction using HIF-1α 
shRNA lentiviral particles (Santa Cruz Biotechnology, Inc., CA, 
USA). Cells expressing shRNA was obtained via selection with 
puromycin (5–10 μg/mL). New media containing fresh puromy-
cin were replaced every 3–4 days until the generation of resistant 
colonies.
Orthotopic xenograft mouse model
Lentiviral control (LVcontrol) and shHIF-1α FTC133 cells were 
harvested by trypsinization and washed with serum-free medi-
um. After randomization into two groups (n=5), FTC133 cells 
(1×105/5 μL) were injected into the right thyroid lobe of 6-week-
old male nude mice (Orientbio Inc., Seongnam, Korea) using a 
Hamilton syringe (Hamilton Company, Reno, NV, USA) and a 
30-G needle as described previously.23 The tumors were allowed 
to develop for 14 days. Animals were euthanized 28 days after 
implantation, and tumors were harvested. All of the animal ex-
perimental procedures were approved by the committee of eth-
ics on animal research of the Yonsei University College of Medi-
cine. All mice were treated in accordance to the guidelines for 
the care and use of laboratory animals of the institutional animal 
care and use committee of the institute. 
Western blotting of HIF-1α, E-cadherin, vimentin, and Twist 
was performed using samples from the specimens. The other half 
of the samples were fixed overnight in neutral buffered formalin, 
after which immunohistochemical staining of tumor tissues was 
performed using primary antibodies against E-cadherin, vimen-
tin, and Twist as described previously.23 The immunostained sec-
tions were analyzed under a Nikon light microscope. Microscopy 
images were captured using AxioCam digital microscope cameras 
and AxioVision image processing software (Carl Zeiss Vision, Ger-
many).
Statistical analysis
All data are represented as means±SD from triplicate experi-
ments. Student’s t-tests and one-way ANOVAs were performed 
using SPSS 20.0 statistical software (SPSS, Chicago, IL, USA). 
p<0.05 was considered statistically significant (*p<0.05; **p<0.01; 
***p<0.001).
RESULTS
Hypoxia induces HIF-1α expression in thyroid cancer 
cells
We examined the level of HIF-1α expression in selected follicu-
lar (FTC133 and ML1), papillary (BCPAP and TPC1), and ana-
plastic thyroid cancer cells (8505C and FRO) under hypoxic 
conditions in vitro. As shown in Fig. 1A, all cell lines expressed 
relatively high levels of HIF-1α protein after exposure to hypox-
ia. This was most prominent in FTC133 cells, which have lost 
PTEN expression. Consistent with hypoxia-induced HIF-1α 
http://dx.doi.org/10.3349/ymj.2015.56.6.15031506
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protein levels, HIF-1α mRNA levels also increased under hy-
poxic conditions (Fig. 1B). Next, we determined the localization 
of HIF-1α expression in each type of thyroid cancer using im-
munocytochemistry. Consistent with the immunoblotting and 
RT-PCR results, the fluorescence of HIF-1α was most strongly 
enhanced in FTC133 cells under hypoxic conditions and corre-
lated with DAPI staining of the nucleus (Fig. 1C).
HIF-1α
DAPI
Merge
FTC133 TPC1 8505C
Normoxia Normoxia NormoxiaHypoxia Hypoxia Hypoxia
C
GAPDH
HIF-1α
FTC133 TPC1 8505C
N N NH H H
B
GAPDH
HIF-1α
FTC133
FTC PTC ATC
ML1 BCPAP TPC1 8505C FRO
N N N N N NH H H H H H
A
Fig. 1. Hypoxia-induced HIF-1α expression in cell lines derived from different types of thyroid cancers. All cells were harvested after 16 h under nor-
moxic or hypoxic conditions (1% O2), and HIF-1α expression was analyzed using the following methods. (A) Western blot analysis of HIF-1α in thyroid 
cancer cell lines derived from follicular (FTC133 and ML1), papillary (BCPAP and TPC1), and anaplastic (8505C and FRO) carcinomas. (B) Total RNA 
isolated from each selected thyroid cancer cell line. Cell lines with high protein expression of HIF-1α under hypoxic conditions (FTC133, TPC1, 8505C) 
were analyzed for the presence of HIF-1α transcripts using real-time PCR with primers specific for HIF-1α. (C) Immunofluorescence staining of HIF-1α 
expression in thyroid cancer cells. Cells were incubated under normoxic or hypoxic conditions for 16 hours, followed by immunofluorescence analy-
sis. HIF-1α, green; DAPI, blue. Hypoxia-induced HIF-1α expression was highest in FTC133 cells. Scale bar=50 μm. Each figure is representative of trip-
licate experiments. FTC, follicular thyroid cancer; PTC, papillary thyroid cancer; ATC, anaplastic thyroid cancer; HIF-1α, hypoxia inducible factor-1α.
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exposure to hypoxic conditions for 16 h, appearing flattened, 
spindle-shaped, and fibroblast-like, characterized by many 
cytoplasmic projections and loss of tight cell-to-cell junctions, 
whereas control cells under normoxia showed robust cellular 
junctions with a cobblestone-like, epithelial appearance (Fig. 
2A). Acquisition of the mesenchymal-like morphologic phe-
Hypoxia regulates epithelial-to-mesenchymal transi-
tion in thyroid cancer cells
To investigate whether hypoxia induces EMT in thyroid cancer 
cells, we first investigated the morphologic appearance of can-
cer cells under microscopy. All thyroid cancer cells (FTC133, 
TPC1, and 8505C) showed typical morphologic changes after 
FTC133
Normoxia Hypoxia
TPC1
8505C
A
C
B
HIF-1α
E-cadherin
Vimentin
N-cadherin
Twist
Slug
GAPDH
FTC133 TPC1 8505C
N N NH H H
FTC133
TPC1
8505C
E-cadherin Vimentin
Normoxia NormoxiaHypoxia Hypoxia
Fig. 2. Hypoxia-induced EMT in thyroid cancer cell lines (FTC133, TPC1, and 8505C). All cells were incubated under normoxia or hypoxia (1% O2) for 16 
h. (A) External cell morphology was analyzed under a phase-contrast microscope. After exposure to hypoxic conditions, cells appeared to be flatter, 
elongated, and ramified with long extending processes. Loss of cell-to-cell contact was also noted after hypoxia (×200). Scale bar=50 μm. (B) West-
ern blot analysis of signals related to EMT using the indicated antibodies revealed that the expression of a general epithelial marker (E-cadherin) de-
creased and that of mesenchymal markers (N-cadherin and vimentin) increased under hypoxic conditions. In addition, a downstream transcription 
factor, Twist, was also increased after hypoxia exposure. (C) Immunofluorescence assays using Alexa 568 (red)- or Alexa 488 (green)-labeled antibod-
ies (1:250) to visualize E-cadherin (red) or vimentin (green), respectively, in each cell line; DAPI was used to label cell nuclei (blue). Changes consistent 
with the Western blotting results were noted using confocal microscopy and were most intense in FTC133 cells. Scale bar=50 μm. Each figure is repre-
sentative of triplicate experiments. HIF-1α, hypoxia inducible factor-1α; FTC, follicular thyroid cancer; EMT, epithelial-to-mesenchymal transition.
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notype was most apparent in FTC133 cells.
Next, we evaluated EMT-related protein expression (E-cad-
herin, vimentin, N-cadherin, Twist, and Slug) using Western blot 
analysis. As shown in Fig. 2B, after 16 h incubation under hypox-
ia, expression of the epithelial marker E-cadherin was de-
creased, whereas the expression of mesenchymal markers vi-
mentin and N-cadherin significantly increased in FTC133 cells. 
Interestingly, the expression of Twist, a master EMT regulator,24 
also markedly increased after exposure to hypoxia in FTC133 
cells. Even though another EMT related transcription factor, 
Slug,25 showed faint expression even under hypoxia, a slight aug-
mentation in expression was noted under hypoxic conditions 
only in FTC133 cells. Consistent with the immunoblot results, E-
cadherin downregulation and vimentin augmentation were 
noted in the immunofluorescence analysis (Fig. 2C). 
Cells with hypoxia-induced EMT phenotypes show 
high invasiveness in vitro
To investigate whether cells that have undergone hypoxia-in-
duced EMT exhibit changes in invasion ability, a transwell as-
say was performed to determine single cancer cell invasion. As 
shown in Fig. 2D, all the thyroid cancer cells were more invasive 
after exposure to hypoxia. FTC133 cells had more than 12-fold 
increase in gel invasion (p<0.01), whereas there was approxi-
mately 5-fold and 8-fold increase in TPC1 and 8505C cells, re-
spectively (p<0.01 and p<0.01).
Overexpression of HIF-1α induces epithelial-to-
mesenchymal transition in follicular thyroid cancer
To determine the association between HIF-1α expression and 
EMT in aggressive tumor invasion, we transfected a plasmid 
(pcDNA3-HIF-1α) encoding human HIF-1α into FTC133 cells, 
which showed the highest induction of HIF-1α and acquisition 
of mesenchymal morphologic characteristics under hypoxia. As 
shown in Fig. 3A, FTC133 cells transfected with the HIF-1α vec-
tor showed mesenchymal morphologic changes, even under 
normoxia, similar to those in cells exposed to hypoxic condi-
tions. Interestingly, Western blotting and real-time PCR showed 
similar changes in EMT marker expression under hypoxia in 
HIF-1α-overexpressing FTC133 cells (Fig. 3B and C). In addition, 
as shown in Fig. 3D, HIF-1α overexpression alone led to a simul-
taneous decrease in E-cadherin fluorescence and increase in vi-
mentin fluorescence. Furthermore, as shown by the invasion 
assay, HIF-1α overexpression increased the invasiveness of 
FTC133 cells by approximately 7-fold (p<0.01) (Fig. 3E). 
Constitutive knockdown of HIF-1α expression 
reduced hypoxia-induced epithelial-to-mesenchymal 
transition in follicular thyroid cancer
To confirm the significance of HIF-1α in hypoxia-induced EMT 
in FTC133 cells, we blocked the HIF-1α pathway in FTC133 cells 
by constitutive expression of shRNA. As shown in Fig. 4A and B, 
HIF-1α expression was diminished by shRNA under normoxia, 
and there was little increase in HIF-1α expression even after 
Fig. 2. Hypoxia-induced EMT in thyroid cancer cell lines (FTC133, TPC1, and 8505C). All cells were incubated under normoxia or hypoxia (1% O2) for 16 
h. (D) Transwell invasion assays were performed to evaluate the invasive ability of cells. FTC133, TPC1, and 8505C cells were seeded on a filter (pore 
size, 8 coated μm) coated with Matrigel in the upper compartment and exposed to a normoxic or hypoxic environment. After 12 h, the cells in the 
pores or cells attached to the undersurface of the membrane were counted, while those attached to the lower section were stained with crystal vio-
let (panel) and counted using a light microscope (graph) (×200). Scale bar=250 μm. The data represent mean±SD of three independent experiments. 
**p<0.01. EMT, epithelial-to-mesenchymal transition; FTC, follicular thyroid cancer.
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hypoxic stimulation compared with the LVcontrol. We then 
assessed whether suppression of HIF-1α could modulate the 
expression of EMT markers. As expected, blocking HIF-1α via 
shRNA diminished the hypoxia-induced changes in E-cad-
herin, vimentin, and Twist expression at both the protein and 
mRNA levels (Fig. 4B and C). Immunofluorescent analysis of E-
cadherin and vimentin showed similar results to Western blot-
ting and real-time PCR (Fig. 4D). Moreover, suppression of HIF-
1α expression significantly decreased the number of invasive 
FTC133 cells compared with the control under hypoxic condi-
tions (p=0.003) (Fig. 4E). Fig. 4F demonstrates that under hy-
poxic conditions, wound closure in LVcontrol FTC133 cells sig-
nificantly increased (from 1.6- to 4.3-fold), whereas when HIF-
1α was blocked by shRNA, hypoxia-induced wound closure 
decreased, resulting in no significant changes across the de-
nuded zone between hypoxia and normoxia. These results in-
dicate that HIF-1α is a crucial molecular signal inducing EMT 
in FTC133 cells.
Suppression of HIF-1α decreased epithelial-to-
mesenchymal transition of follicular thyroid cancer in 
the orthotopic xenograft murine model
To investigate whether the aforementioned results were evi-
dent in vivo, we used an FTC133 orthotopic xenograft mouse 
model generated by injection of shHIF-1α cells or LVcontrol 
cells into the thyroid gland. All mice survived the experimental 
period. As Fig. 5A shows, tumors induced by shHIF-1α cells 
were significantly smaller in both tumor volume (p=0.002) and 
weight (p<0.001) than those induced by LVcontrol cells 28 days 
after injection. Next, we performed histologic analysis of tumor 
tissues from each group of animals. Using lower power obser-
vations (upper row of Fig. 5B, ×100) after hematoxylin and eo-
Fig. 3. HIF-1α overexpression promotes EMT in FTC133 cells even under normoxia. FTC133 cells were transfected transiently with either empty vector 
(Control) or pcDNA3-HIF-1α (pcHIF-1α) and maintained under normoxia. (A) After a 48-hr transfection period, morphological changes in cells were 
analyzed under a phase-contrast microscope (×200). HIF-1α overexpression induced typical EMT morphologic changes, including increased cyto-
plasmic projection (black arrowheads). Scale bar=50 μm. E-cadherin, vimentin, and Twist expression was evaluated by (B) Western blot analysis, (C) 
real-time PCR using GAPDH as an internal control, and (D) immunofluorescence analysis in HIF-1α-transfected FTC133 cells. DAPI was used to label 
cell nuclei (blue). Scale bar=50 μm. (E) Transwell invasion assay results revealed that HIF-1α overexpression significantly increased the invasive abili-
ty of FTC133 cells. The panel is representative of triplicate experiments. Scale bar=250 μm. Graphs show quantification of the transwell assay. The 
data represent mean±SD of three independent experiments. *p<0.05, **p<0.01, ***p<0.001. HIF-1α, hypoxia inducible factor-1α; EMT, epithelial-to-
mesenchymal transition; FTC, follicular thyroid cancer.
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Fig. 4. Knockdown of HIF-1α in FTC133 cells reverses hypoxia-induced EMT. Stable silencing of HIF-1α was performed using shRNA lentiviral particles 
(shHIF-1α). The lentiviral vector was used as the empty control vector (LVcontrol). All cells were incubated under normoxia or hypoxia (1% O2) for 16 h. 
(A) shHIF-1α transduction repressed hypoxia-induced HIF-1α activation in FTC133 cells. HIF-1α and EMT marker (E-cadherin, vimentin, and Twist) ex-
pression was evaluated by (B) Western blot analysis, (C) real-time PCR using GAPDH as an internal control, and (D) immunofluorescence analysis in 
HIF-1α knockdown FTC133 cells. DAPI was used to label cell nuclei (blue). Scale bar=20 μm. (E) Transwell invasion assay and (F) scratch-wound heal-
ing assay revealed that HIF-1α suppression significantly decreased the invasion and migration of FTC133 cells. Each panel was representative of trip-
licate experiments. Scale bars=250 μm and 200 μm, respectively. Graphs show quantification of each assay. The data represent mean±SD of three 
independent experiments. *p<0.05, **p<0.01. HIF-1α, hypoxia inducible factor-1α; EMT, epithelial-to-mesenchymal transition; FTC, follicular thyroid 
cancer; LVcontrol, lentiviral control; NS, not significant.
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Fig. 5. Knockdown of HIF-1α by specific shRNA reduces EMT in an orthotopic FTC murine model. To determine whether the aforementioned results 
were evident in vivo, stable shHIF-1α FTC133 cells (1×105/mouse) were injected into the right side of the thyroid gland in 6-week-old male nude mice 
(n=5). Twenty-eight days after inoculation with FTC133 cells, tumors were harvested for Western blotting and histologic evaluations including H&E 
staining and immunohistochemical analysis. (A) Representative image of tumors. Tumors derived from shHIF-1α cells showed significantly decreased 
tumor volume and weight compared with that from LVcontrol cells. Scale bar=10 mm. (B) H&E stain of tumor derived LVcontrol cells showed more in-
vasive features than that from shHIF-1α cells. Upper panel (×100): tumors derived from shHIF-1α cells had a clear boundary between the tumor and 
adjacent nontumor tissue (arrowheads), whereas tumors induced by LVcontrol cells demonstrated irregular invasive fronts. Lower panel (×200): tu-
mor cell invasions into blood vessel forming tumor embolis (arrows) are noted in the tissue from LVcontrol group, whereas no definite tumor emboli in 
that from shHIF-1α group. Scale bar=50 μm. (C) Representative immunohistochemical results showed more intense staining of E-cadherin, but weak-
er staining of vimentin and Twist, supporting the in vitro results. Scale bar=100 μm. (D) Western blot analysis of HIF-1α, E-cadherin, vimentin, and Twist 
showed similar changes to those seen in vitro. **p<0.01, ***p<0.001. M, muscle; Tu, tumor; V, vessel; HIF-1α, hypoxia inducible factor-1α; EMT, epithe-
lial-to-mesenchymal transition; FTC, follicular thyroid cancer; LVcontrol, lentiviral control; H&E, hematoxylin and eosin.
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sin staining, tumor from LV control group showed more aggres-
sive feature of infiltration to adjacent muscles whereas that 
from shHIF-1α group maintained clear demarcation from sur-
rounding muscle (arrowhead). In addition, we found frequent 
vascular invasion of tumor embolis (arrow, lower row of Fig. 5B, 
×200) in the vascular area of specimens from LVcontrol group, 
whereas no vascular invasion was identified tumors from shHIF-
1α group. Tumor tissue sections were then stained to determine 
the expression of HIF-1α, E-cadherin, vimentin, and Twist. Tu-
mor tissues derived from shHIF-1α FTC133 cells showed mark-
edly stronger E-cadherin staining and weaker vimentin and 
Twist staining compared with that from LVcontrol group (Fig. 
5C). Furthermore, as shown in Fig. 5D, tumor tissues derived 
from shHIF-1α cells had markedly lower expressions of HIF-1α, 
vimentin, and Twist, and increased expression of E-cadherin 
compared with the LVcontrol. These data are consistent with the 
in vitro findings, suggesting that HIF-1α induces EMT, which is 
associated with Twist in FTC cells, even without hypoxia.
DISCUSSION
Cancer cell invasion or metastasis to other tissues or organs 
leads to a decrease in prognosis and survival.26 For this, identi-
fying and controlling the mechanisms of invasion or metastasis 
remains one of the main foci of cancer therapeutics. Although 
increasing evidence suggests that activation of the Ras-Raf-Mek-
ERK pathway is important in the development of PTC,21,27 the 
molecular mechanism contributing to FTC is poorly defined.16 A 
number of genetic abnormalities have been reported in human 
FTCs, such as mutations in RAS,28 PAX8-PPARγ rearrangement,29 
and PTEN,30 and Prkar1a deletion.31 However, the association of 
these mutations with tumorigenesis and aggressive features is 
less clear, because tumor development is unreliable and does not 
exhibit distant metastasis, which is a typical feature of human 
FTC.30 In this study, we showed that HIF-1α plays a crucial role in 
the migration and invasion of FTC via triggering EMT in vivo 
orthotopic FTC murine model, as well as in vitro.
HIF-1, which is a heterodimer complex containing two basic 
helix-loop-helix (bHLH) transcription factors (HIF-1α and HIF-
1β), is the main responder to hypoxia.16,18 Under hypoxic condi-
tions, stabilized HIF-1α translocates from the cytoplasm to the 
nucleus to dimerize with HIF-1β and activates downstream tar-
get genes that contribute to cancer progression and promote 
tumor aggressiveness, leading to metastasis or resistance to 
therapy.19 Intratumoral hypoxia followed by HIF-1α overexpres-
sion is associated with tumor invasiveness and metastasis in 
various cancers.15,20 In our study, among the cell lines exam-
ined, HIF-1α was significantly activated under hypoxia in 
FTC133 cell line, even though basal expression levels were 
higher in ATC cells. This observation is in accordance with pre-
vious work by Jubb, et al.32 who reported particularly high ex-
pression levels of HIF-1α in FTCs.16 The highly induced activa-
tion of HIF-1α by hypoxia may be supported by PTEN loss in 
FTC133 cell line.30 Increasing evidence suggests that PTEN loss 
is involved in HIF-1α regulation and in aggressiveness, thera-
peutic resistance, and metastasis of cancer.33,34 Moreover, Bur-
rows, et al.10 showed that reintroduction of PTEN into cells re-
duced HIF-1α activity.
The transition of an epithelial carcinoma to a mesenchymal 
phenotype (EMT) is characterized by immense morphologic 
changes marked by loss of polarity and cell-to-cell contacts, and 
an enhanced ability to migrate through the neighboring extra-
cellular matrix.8 The molecular hallmarks for EMT are downreg-
ulation of epithelial cell cadherin molecules, such as E-cadherin, 
and upregulation of mesenchymal components, such as vimen-
tin and N-cadherin.35 In the present study, thyroid cancer cells, es-
pecially FTC133 cells, showed typical EMT morphologic changes 
under hypoxic stress, implying that hypoxia induces EMT. This 
was confirmed by changes in molecular marker expression, in-
cluding a cadherin switch (decrease of E-cadherin, increase of N-
cadherin). Cadherin switch, a hallmark of EMT, was reported to 
play an important role in promoting cell mobility and invasion.9 
Many solid tumor cells have been observed to undergo a cad-
herin switch, which was suggested to be part of the initial tumor 
invasion cascade.36,37 Moreover, these changes augmented the 
ability of cells to invade and migrate, which is regulated by HIF-
1α overexpression or suppression. These data suggest that HIF-
1α could regulate EMT in FTC133 cells independent of oxygen 
condition. 
Multifarious transcriptional factors, including Snail,38 Slug,39 
Twist,24 Zeb1,40 SIP1,41 and E47,42 were shown to induce EMT 
through the cadherin switch and are perceived as EMT regula-
tors.38 In this study, we showed that Twist expression was in-
creased by hypoxic stress. Interestingly, overexpression of HIF-
1α alone augmented the expression of Twist, while suppression 
of HIF-1α abolished the hypoxia-induced increases in Twist ex-
pression in FTC133 cells, suggesting that Twist is regulated by 
HIF-1α in this cell line. Twist is another bHLH transcription fac-
tor and one of the master regulators of the EMT process.43 The 
gene for Twist (TWIST1) is located on human chromosome 
7p21.44 Since Yang, et al.24 initially reported Twist as be an essen-
tial factor in cancer metastasis, more evidence has demonstrated 
associations of Twist with a more aggressive phenotype and a 
worse prognosis in human cancers via Twist-induced EMT.43,45 
As expected by its EMT-inducing capabilities, Twist causes the 
tumor cells to switch to extravasation, associated with the forma-
tion of membrane protrusions, resulting in intravascular migra-
tion and extravasation through the vessel wall, which is essen-
tial to the metastatic process.46 Moreover, Twist is capable of 
promoting the formation of invadopodia, specialized mem-
brane protrusions for extracellular matrix degradation.47 The 
morphologic changes observed in the present study are consis-
tent with the Twist-associated tumor cell changes typically seen 
during the EMT process. 
Recent studies demonstrated that HIF-1α and Twist are part 
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of the same pathway that regulates cancer invasion and metas-
tasis.24 Moreover, Twist is a direct target of HIF-1α with a func-
tional HRE present in the promoter of the Twist gene.45 In ad-
dition, several studies showed that co-expression of HIF-1α 
and Twist is involved in metastasis and poor prognosis in sev-
eral cancers.43,48 To the best of our knowledge, we are the first 
to report that HIF-1α mediates hypoxic responses and pro-
motes EMT through upregulation of Twist expression in FTC 
cells. These observations were confirmed in vivo using an or-
thotopic xenograft FTC model.
In conclusion, this study demonstrates that HIF-1α plays a 
crucial role in hypoxia-induced EMT in FTC133 cells. More-
over, the molecular mechanism involves Twist signaling and 
its regulation by HIF-1α. These results suggest that HIF-1α and 
Twist are promising molecular targets that may contribute to 
novel strategies against aggressive and metastatic FTC.
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